RGS6 and neoplasm: Moreover, the Authors managed to link decreased RGS6 expression with clinical parameters, including increased carcino-embryonic antigen (CEA) serum levels, enhanced TNM staging and its components independently: tumor size (T), forming nodular (N) and distant metastases (M), which suggests the anti-tumor properties of RGS6 activity.